RSPH4A-PCDx: An Index to Predict Lung Function Decline in Primary Ciliary Dyskinesia
Advances in Respiratory Medicine · 2025
DOI: 10.3390/arm93040027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Respiratory Medicine, 2025. Verfasst von Gabriel Román-Ríos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Sciences, Ponce Health Sciences University, Ponce, PR 00716, USA. Hauptthemen laut MEDLINE: Ciliary Motility Disorders, Kartagener Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIMHD NIH HHS, Research Centers in Minority Institutions Center for Research Resources.
Abstract (Originalsprache)
Primary ciliary dyskinesia (PCD) is a rare, genetically heterogeneous disorder that impairs mucociliary clearance and leads to progressive lung disease. This study aimed to characterize lung function decline in a genetically homogeneous cohort of Puerto Rican patients with RSPH4A-associated PCD and to develop a clinical tool to predict lung function decline and support transplant referral decisions. We conducted a retrospective chart review of patients (n = 25) with a confirmed RSPH4A [c.921+3_6delAAGT] genetic variant, collecting longitudinal spirometry data and applying linear regressions to calculate each patient’s individual FEV1 decline. The median FEV1 at diagnosis was 55%, with a median annual decline of −0.75% predicted. Adults exhibited significantly lower lung function compared to pediatric patients, while no difference was seen between males and females. Based on this observed decline, we developed the Predicted Capacity Decline Index (PCDx), an index that estimates the age and time until a patient reaches the 30% FEV1 threshold, the point at which lung transplant referral is typically considered. Our findings underscore the need for early intervention and suggest that genotype-specific tools like the PCDx may enhance clinical decision-making in managing progressive lung disease in PCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic Sciences, Ponce Health Sciences University, Ponce, PR 00716, USA.
- Department of Pediatrics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
ORCID-Profile: Gabriel Rosario-Ortiz, Wilfredo De Jesús-Rojas
Förderung
- NIGMS NIH HHS
- NIMHD NIH HHS
- Research Centers in Minority Institutions Center for Research Resources
- PR- INBRE Developmental Research Project Program
- Research Centers in Minority Institutions Center for Research Resources Grant
- Molecular and Genomics Core
Zitieren
APA
Román-Ríos, G., Rosario-Ortiz, G., Ramos-Benitez, M. J., Mosquera, R. A., & De Jesús-Rojas, W. (2025). RSPH4A-PCDx: An Index to Predict Lung Function Decline in Primary Ciliary Dyskinesia. Advances in Respiratory Medicine. https://doi.org/10.3390/arm93040027
Vancouver
Román-Ríos G, Rosario-Ortiz G, Ramos-Benitez MJ, Mosquera RA, De Jesús-Rojas W. RSPH4A-PCDx: An Index to Predict Lung Function Decline in Primary Ciliary Dyskinesia. Advances in Respiratory Medicine. 2025. doi:10.3390/arm93040027
BibTeX
@article{RomnRos2025,
author = {Román-Ríos, Gabriel and Rosario-Ortiz, Gabriel and Ramos-Benitez, Marcos J and Mosquera, Ricardo A and De Jesús-Rojas, Wilfredo},
title = {RSPH4A-PCDx: An Index to Predict Lung Function Decline in Primary Ciliary Dyskinesia},
journal = {Advances in Respiratory Medicine},
year = {2025},
doi = {10.3390/arm93040027}
}
EUVIMED